About Us
Mr Yodaiken’s ARMD patients benefit from his skill and experience in treating retinal disorders.
After qualifying as a physician and completing specialist training as an ophthalmologist in South Africa, Mr Yodaiken relocated to the UK, where he completed fellowships in anterior segment surgery and age-related macular degeneration.
His career in the NHS included a post as a consultant with special interest in medical retina, undertaking over 10,000 injections for ARMD. He now sees patients privately at the Alexandra Hospital, Cheadle, and in his own Salford-based clinic.
Mr Yodaiken’s genuine interest and compassion make him a popular clinician. His belief that patients of any age deserve the best possible care make him an ideal choice of care provider for ARMD patients. When several of his NHS patients were offered care at an alternative clinic, every one of them voted to remain under his care, testifying to the excellent relationship he has with his patients.
Years Of Experience
Injections
CLINIC
Conveniently located within a modern health centre, only a little way from Manchester City Centre, we are easy to find. There is ample parking (including disabled spaces), which is free for two hours, and the building is fully accessible for wheelchair users.
Newbury Place Health Centre
55 Rigby Street
Salford
M7 4NX
Our mission
Our clinic aims to provide personalized care for Age-related macular degeneration patients with empathy and excellence.
Our vision
To become the leading center for Age-related macular degeneration care, advancing innovation and improving patients’ quality of life.
“The clinic where we care about you as well as for you.”
We Have What You Need
Expertise
Highly experienced consultant ophthalmologist specialising in medical retina.
PERSONAL CARE
The same doctor every time for continuity of care and a good patient doctor relationship.
CLOSE MONITORING
Monthly reviews and regular OCT scanning for early identification of disease progression.
THE LATEST TREATMENTS
Access to new treatments currently in development as soon as they are available.